Update in cognitive therapy for depression

Journal of Cognitive Psychotherapy: An International Quarterly

Volumn 14, Issue 3, 2000, Pages 305-336

  Blackburn, I M ^a   Moorhead, S ^a  

^a Newcastle Cognitive and Behavioural Therapies Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CLINICAL FEATURE; COGNITIVE THERAPY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; PSYCHIATRIC DIAGNOSIS; RATING SCALE; REVIEW; SCORING SYSTEM; THINKING; TREATMENT OUTCOME;

EID: 0033773861     PISSN: 08898391     EISSN: None     Source Type: Journal    
DOI: 10.1891/0889-8391.14.3.305     Document Type: Review

References (165)

1. Judgement of contingency in depressed and non-depressed students: Sadder but wiser?
2. A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (Prozac) in the treatment of depression
3. The dexamethasone suppression test: An overview of its current status in psychiatry
4. The dexamethasone supression test for diagnosis and prognosis in psychiatry
5. On second thought: Where the action is in cognitive therapy of depression
6. Reduction of prefrontal cortex glucose metabolism common to three types of depression
7. Thinking and depression. I. Idiosyncratic content and cognitive distortions
8. Thinking and depression. II. Theory and therapy
9. Cognitive models of depression
10. An inventory for measuring depression
11. The measurment of pessimism: The Hoplessnesss Scale
12. Improvement after evaluation in psychotherapy of depression: Evidence of a placebo effect?
13. Psychotherapy of depression. Research at a cross-roads: Directions for the 1990s
14. Changes in cognition with pharmacotherapy and cognitive therapy
15. The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination
16. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression
17. Perceptual and physiological dysfunction in depression
18. Affect and memory: A review
19. Interpersonal factors in brief treatment of depression: Further analysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program
20. Mood and memory
21. Commentary on mood and memory
22. How might emotions affect learning?
23. Theoretical foundations of cognitive behavior therapy for anxiety and depression
24. State and trait differences in depressive self-perceptions
25. Autobiographical memory in depression: State or trait marker?
26. Does homework compliance enhance recovery from depression?
27. Therapeutic empathy and recovery from depression in cognitive behavioural therapy: A structural equation model
28. The diagnosis of depressive syndromes and the prediction of ECT response
29. Predicting the effect of cognitive therapy for depression: A study of unique and common factors
30. Diurnal variation in clinical depression and accessibility of memories of positive and negative experiences
31. Research on symptoms versus research on syndromes: Arguments in favour of allocating more research time to the study of symptoms
32. The role of cognition in depression: A critical appraisal
33. The neuropsychology of depression and its implications for cognitive therapy
34. How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression
35. Determinants of change in cognitive therapy for depression
36. A meta-analysis of the efficacy of cognitive therapy for depression
37. Reliability of a measure of the quality of cognitive therapy
38. Science is not a trial (but it can sometimes be a tribulation)
39. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
40. National Institute of Mental Health Treatment of Depression Collaborative Research Program
41. Reflections on rational-emotive therapy
42. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance
43. Differential relapse following cognitive therapy and pharmacotherapy for depression
44. Theoretical cognitive psychology and mood disorders
45. Cognitive behavioural treatment of residual symptoms in primary major depressive disorder
46. Prevention of recurrent depression with cognitive behaviour therapy
47. Metacognition and cognitive monitoring: A new era of cognitive developmental inquiry
48. Researcher allegiance and meta-analysis: The case of cognitive therapy for depression
49. Shifts in affective balance during cognitive therapy of major depression
50. Examination of pre-and posttreatment MHPG during cognitive therapy
51. A meta analysis of the effects of cognitive therapy in depressed patients
52. Cognitive behavioural treatment for depression. Relapse prevention
53. Empirical status of cognitive theory of depression
54. A rating scale for depression
55. The World Health Organisation. High depression rate triggers new campaign
56. Left frontal hypoactivation in depression
57. Cognitive mediation of relapse prevention following treatment for depression: Implications of differential risk
58. Cognitive therapy and pharmacotherapy for depression: Singly and in combination
59. Cognitive self-statements in depression. Development of all automatic thoughts questionnaire
60. Contributions of cognitive psychology to assessment and treatment of depression
61. The personality and diagnostic questionnaire: Development and preliminary results
62. Toward an information processing analysis of depression
63. Depressive cognition: Models, mechanisms and methods
64. A component analysis of cognitive-behavioural treatment for depression
65. Cognitive-behavior therapy versus pharmacotherapy: Now that the jury's returned its verdict, it's time to present the rest of the evidence
66. Mechanisms of change in cognitive therapy of depression
67. Clinical, cognitive and demographic predictors of response to cognitive therapy for depression: A preliminary report
68. Does learned resourcefulness predict response to cognitive therapy in depressed outpatients?
69. Does the pretreatment polysommogram predict response to cognitive therapy in depressed outpatients? A preliminary report
70. Prediction of outcome with group cognitive therapy for depression
71. Dysfunctional attitudes and the cognitive therapy for depression
72. The psychology of the unknown
73. Lifetime and 12-month prevalence of DSM III R psychiatric disorders in the United States. Results from the National Comorbidity Survey
74. The cost of depression
75. Endogenomorphic depression
76. NIMH collaborative research on treatment of depression
77. Preventing hung juries about therapy studies
78. Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program general effectiveness report
79. Cognitive behavioral treatment for depressed adolescents
80. Effect of depression on the speed of recall of pleasant and unpleasant experiences
81. Introduction to special section: Theoretical development in the cognitive psychotherapies
82. Recent developments in cognitive approaches to counseling and psychotherapy
83. Dexamethasone suppresion test and response to cognitive therapy and antidepressant medication
84. Severity of unipolar depression and choice of treatment
85. Experimental construct validity in the evaluation of cognitive and behavioral treatments for depression
86. Effectiveness of cognitive therapy training
87. Dysfunctional attitudes are mood state dependent
88. Cognitive therapy in the treatment of nonresponders to antidepressant medication: A controlled study
89. Cognitive therapy and pharmacotherapy, singly and together in the treatment of depression
90. An appraisal of constructivist psychotherapies
91. Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive behavioral therapy
92. Responses to depression and their effects on the duration of depressive episodes
93. Do cognitive behaviour therapies validate cognitive models of mood disorders? A review of the empirical evidence
94. Process and metacognitive dimensions of depression and anxious thoughts and relationships with emotional intensity
95. Recognition and management of depression in general practice: Consensus Statement
96. The process of change in cognitive therapy: Schema change or acquisition of compensatory skills?
97. Mechanisms of action of cognitive therapy: The relative contributions of technical and interpersonal interventions
98. An expanded attributional style questionnaire
99. Self-regulatory preservation and the depressiveself-focusing style: A self-awareness theory of reactive depression
100. The primacy of affect: Some theoretical implications
101. A reassessment of the 'primacy of affect.' Cognitive Therapy and Research
102. An appraisal of cognitive therapy
103. Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research
104. A schedule for assessing self-control behaviours: Preliminary findings
105. Comparative efficacy of cognitive therapy versus pharmacotherapy in outpatient depression
106. Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms
107. Comparison of the effects of cognitive therapy and pharmacotherapy on hopelessness and self-concept
108. Psychological well-being
109. The internal dialogue: On asymmetry between positive and negative coping thoughts
110. Explanatory style change during cognitive therapy for unipolar depression
111. Effects of treatment duration and severity on depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy
112. Personality disorders and treatment outcome in the NIMHT Treatment of Depression Collaborative Research program
113. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program
114. The process of change in cognitive therapy and pharmacotherapy for depression: Changes in mood and cognition
115. Predicting response to cognitive therapy of depression
116. Biological markers treatment outcome, and 1 year follow-up of endogenous depression: Electroencephalographic sleep studies and cognitive therapy
117. Mode-specific effects among three treatments for depression
118. Research diagnostic criteria: Rationale and reliability
119. Imipramine is effective after unsuccessful cognitive therapy: Sequential use of cognitive therapy and impramine in depressed out-patients
120. Illusion and well-being
121. Negative thinking in depression: Cause-effect or reciprocal relationship?
122. Emotion and two kinds of meaning: Cognitive therapy and applied cognitive science
123. Clinically relevant theory: Integrating clinical insight with cognitive science
124. The relationship between cognition and emotion: The mind in place in mood disorders
125. Metacognition, mindfulness and the modification of mood Disorders
126. Immediate effects on depression of cognitive therapy interventions
127. Cognitive therapy for major depressive disorders in primary care
128. Differential effects of induced mood on retrieval of pleasant and unpleasant events from episodic memory
129. Cognitive behavior therapy and relapse of nonbipolar depression: Parallels with pharmacotherapy
130. Hypothcelamic-pituatary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalised depressed patients
131. Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression
132. Polysomnographic studies of unmedicated depressed men before and after treatment with cognitive behavior therapy
133. Abnormal Electroencephalographic sleep profiles in major depression: Association with response to cognitive behavior therapy
134. Severity of depression and response to cognitive behavior therapy
135. Mood state-dependent memory: A meta-analysis
136. The Cognitive Therapy Scale: Psychometric properties
137. Modelling cognition in emotional disorder. The S-REF model
138. Mediators and moderators of change in cognitive therapy of depression
139. Feeling and thinking: Preferences need no inferences